Public Health Service Inter-Agency Guidelines for Screening Donors of Blood, Plasma, Organs, Tissues, and Semen for Evidence

CDC STACKS serves as an archival repository of CDC-published products including scientific findings, journal articles, guidelines, recommendations, or other public health information authored or co-authored by CDC or funded partners. As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.

Public Health Service Inter-Agency Guidelines for Screening Donors of Blood, Plasma, Organs, Tissues, and Semen for Evidence

April 19, 1991
By National Center for Infectious Diseases (U.S.). Division of Viral Hepatitis.
Source: Morbidity and Mortality Weekly Report (MMWR): Recommendations and Reports, 1991; v. 40, no. 4
Series: Recommendations and Reports: Morbidity and Mortality Weekly Report (MMWR)

English

Details Supporting Files You May Also Like

Details:

Journal Article:

Morbidity and Mortality Weekly Report (MMWR): Recommendations and Reports
Corporate Authors:

National Center for Infectious Diseases (U.S.). Division of Viral Hepatitis.
Description:

Several infectious agents transmit through infected blood and blood products. To decrease the potential for disease transmission, donors are screened for risk factors by medical history and for evidence of infection by specific testing. The Food and Drug Administration (FDA) currently requires that all donations of whole blood and transfusable components as well as plasma for fractionation into injectable derivatives be subjected to a serologic test for syphilis, hepatitis B surface antigen (HBsAg), and antibody to the human immunodeficiency virus (anti-HIV). The FDA also currently recommends testing donations of whole blood and components for transfusion for antibody to human T lymphotropic virus type I (anti-HTLV-I) and antibody to hepatitis C virus (anti-HCV), and is considering recommending testing for antibody to hepatitis B core antigen (anti-HBc). Blood banks in the United States voluntarily began testing donations for anti-HBc and alanine aminotransferase (ALT) in 1986 and 1987 and for anti-HCV in 1990.
Subjects:

[+]

Blood Donors Female Hepacivirus Hepatitis Antibodies Hepatitis B Hepatitis B Virus Hepatitis C Humans Infant Male Mass Screening Pregnancy Sensitivity And Specificity Sperm Banks Tissue Donors
Source:

Morbidity and Mortality Weekly Report (MMWR): Recommendations and Reports, 1991; v. 40, no. 4
Series:

Recommendations and Reports: Morbidity and Mortality Weekly Report (MMWR)
ISSN:

1057-5987 (print)
Pubmed ID:

1850496
Document Type:

Journal Article
Place as Subject:

United States
Pages in Document:

17 pdf pages
Volume:

40
Issue:

4
Peer Reviewed:

Yes
Collection(s):

Guidelines and Recommendations Morbidity and Mortality Weekly Report (MMWR)
Main Document Checksum:

[+]

urn:sha-512:75a8c9ee8314a318b85ad416ee045d2ec16fa05391863b67c2f2147d63e04e0140bf725f3145231adb1b8fb4fbd63fc6d201f60f165a82128e72c97e1a70cfa4
Download URL:

https://stacks.cdc.gov/view/cdc/7321/cdc_7321_DS1.pdf
File Type:

[PDF-325.43 KB]

HTML code for article

bin